Literature DB >> 18930854

Solubility and dissolution improvement of Rofecoxib using solid dispersion technique.

Mohamed Rahamathulla1, Gangadharappa Hv, Neelkant Rathod.   

Abstract

Rofecoxib (RXB) is a potent and selective cyclo-oxygenase-2 (COX-2) inhibitor, highly effective in the treatment of various pains, inflammatory condition, post-operative pain, rheumatoid arthritis, other musculo-skeletal and joint disorders. Although they are completely absorbed upon oral administration, the peak plasma concentration is reached 2-3 hours after oral ingestion. The reason for delay being slow rate of absorption due to poor aqueous solubility. An attempt has been made to enhance solubility and dissolution of rofecoxib by solid dispersion(SD) technique using various hydrophilic excipients like PEG 4000, PEG 6000, PVP at different ratios by melting method and solvent evaporation method. The prepared SD of RXB were characterized to various physico-chemical properties and in vitro drug dissolution studies in 0.1N HCl with 0.25% SLS (pH 1.1) media for a period of 90 min using USP XXIII electro lab 8 basket tab dissolution test apparatus using paddle. The result of study indicated that there was no drug-polymer interaction found. The drug dissolution was found to enhance percent in PEG 4000, PEG 6000 and PVP, after 90 mins of dissolution study 79.02%, 88.02%, 98.57% respectively. On comparison of various polymers used at varied concentrations PVP at 75:25 ratio by fusion method was found to be best suitable for the enhancement of dissolution and solubility of RXB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930854

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  4 in total

1.  Formulation and evaluation of a protein-loaded solid dispersions by non-destructive methods.

Authors:  Ziyaur Rahman; Ahmed S Zidan; Mansoor A Khan
Journal:  AAPS J       Date:  2010-02-03       Impact factor: 4.009

2.  Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status.

Authors:  Harikesh Kalonia; Puneet Kumar; Anil Kumar; Bimla Nehru
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

3.  Development and Characterization of Oral Raft Forming In Situ Gelling System of Neratinib Anticancer Drug Using 32 Factorial Design.

Authors:  Umme Hani; Mohamed Rahamathulla; Riyaz Ali M Osmani; M Yasmin Begum; Shadma Wahab; Mohammed Ghazwani; Adel Al Fatease; Ali H Alamri; Devegowda V Gowda; Ali Alqahtani
Journal:  Polymers (Basel)       Date:  2022-06-21       Impact factor: 4.967

4.  Solid Dispersion Approach Improving Dissolution Rate of Stiripentol: a Novel Antiepileptic Drug.

Authors:  Samar Afifi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.